Advanced in Disseminated Intravascular Coagulation

Ting Niu

Chengdu, CN 
Advanced in Disseminated Intravascular Coagulation
Chengdu, CN 
OverviewLocationsClinical Research

Overview

Ting Niu practices in Chengdu, China. Ms. Niu is rated as an Advanced expert by MediFind in the treatment of Disseminated Intravascular Coagulation. Her top areas of expertise are Multiple Myeloma, Adult Immune Thrombocytopenia, Peripheral T-Cell Lymphoma, Splenectomy, and Bone Marrow Transplant.

Her clinical research consists of co-authoring 240 peer reviewed articles and participating in 3 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, she has co-authored 5 articles in the study of Disseminated Intravascular Coagulation.

Gender
Female

Locations

Chengdu, 610041, China
Other Locations
China
Haikou, China
Key Laboratory Of Cardiovascular Remodeling And Function Research, Jinan, China

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

3 Clinical Trials

A Phase III, Open-Label, Randomized Study to Evaluate the Efficacy and Safety of Single Agent Belantamab Mafodotin Compared to Pomalidomide Plus Lowdose Dexamethasone (Pom/Dex) in Participants With Relapsed/Refractory Multiple Myeloma (RRMM) (DREAMM 3)
A Phase III, Open-Label, Randomized Study to Evaluate the Efficacy and Safety of Single Agent Belantamab Mafodotin Compared to Pomalidomide Plus Lowdose Dexamethasone (Pom/Dex) in Participants With Relapsed/Refractory Multiple Myeloma (RRMM) (DREAMM 3)
Enrollment Status: Active_not_recruiting
Publish Date: June 10, 2025
Intervention Type: Drug
Study Drugs: Belantamab Mafodotin, Pom/Dex (Pomalidomide plus Low Dose Dexamethasone)
Study Phase: Phase 3
A National, Prospective, Non-interventional Study of NINLARO in Real World Clinical Practice
A National, Prospective, Non-interventional Study of NINLARO in Real World Clinical Practice
Enrollment Status: Active_not_recruiting
Publish Date: April 10, 2025
Observational, Non-interventional, Multicenter Study Aimed at Collecting Prospective Data Related to Study Safety and Effectiveness in Real Clinical Practice in Patients With CD30+ Lymphoma (BRAVE Study)
Observational, Non-interventional, Multicenter Study Aimed at Collecting Prospective Data Related to Study Safety and Effectiveness in Real Clinical Practice in Patients With CD30+ Lymphoma (BRAVE Study)
Enrollment Status: Active_not_recruiting
Publish Date: January 27, 2025
Intervention Type: Other
View 2 Less Clinical Trials

240 Total Publications

Development, reliability, and validity of a treatment-related quality of life scale for Chinese patients with multiple myeloma
Development, reliability, and validity of a treatment-related quality of life scale for Chinese patients with multiple myeloma
Journal: Zhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi
Published: October 14, 2025

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Ms. Niu's expertise for a condition
ConditionClose
    View All 20 Advanced Conditions
    View All 43 Experienced Conditions
    Want to save this expert for later?
    Sign Up
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile